4 Results for "

PROTAC ER Degrader-10

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PROTAC ER Degrader-10" in MCE Product Catalog:

Cat. No.: HY-145073
CAS No.: 2504911-58-2
Research Areas:  

Cancer

PROTAC ER Degrader-10 is a potent PROTAC ER degrader and can be used for cancer research. PROTAC ER Degrader-10 is extracted from patent WO2021133886, example 36.
loading...
    loading...
Cat. No.: HY-170336
CAS No.: 2421260-43-5
Research Areas:  

Cancer

PROTAC ERα Degrader-10 is an orally active estrogen receptor α (ERα) PROTAC degrader, with DC50 values of 0.37, 1.1, and 0.47 nM in MCF7, T47D, and CAMA-1 cells, respectively. PROTAC ERα Degrader-10 exhibits significant anti-tumor activity both in vitro and in vivo, and can be used for breast cancer research .
loading...
    loading...
Cat. No.: HY-170339
CAS No.: 2421262-07-7
ER ligand-5 is the ligand for estrogen receptor, that can be used as ligand for target protein for PROTAC synthesis of PROTAC ERα Degrader-10 (HY-170336) .
loading...
    loading...
Cat. No.: HY-W998234
CAS No.: 3026842-89-4
Research Areas:  

Cancer

(3S) Lenalidomide-5-Pip-Boc is an E3 ligase ligand-linker conjugate that is applicable to research related to PROTAC synthesis. (3S) Lenalidomide-5-Pip-Boc serves as the E3 ligase ligand-linker conjugate for PROTAC ERα Degrader-10 (HY-170336) and PROTAC ER Degrader-14 (HY-170340) .
loading...
    loading...